ArticleFrontiers in endocrinology2023

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.

Tadesse Asmamaw Dejenie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.